The roles of miR-146a in the differentiation of Jurkat T-lymphoblasts

References

• Dias S, Xu W, McGregor S, Kee B. Transcriptional regulation of lymphocyte development. Curr Opin Genet Dev. 2008;18(5):441–8.
   PubMed Web of Science ®Google Scholar
• Rothenberg EV, Zhang J, Li L. Multilayered specification of the T-cell lineage fate. Immunol Rev. 2010;238(1):150–68.
   PubMedGoogle Scholar
• Taylor A, Verhagen J, Akkoc T, Wenig R, Flory E, Blaser K, et al. IL-10 suppresses CD2-mediated T cell activation via SHP-1. Mol Immunol. [Research Support, Non-U.S. Gov't] 2009;46(4):622–9.
   Google Scholar
• Dave VP. Role of CD3 epsilon-mediated signaling in T-cell development and function. Crit Rev Immunol. [Research Support, Non-U.S. Gov't Review] 2011;31(1):73–84.
   PubMed Web of Science ®Google Scholar
• Graux C, Cools J, Michaux L, Vandenberghe P, Hagemeijer A. Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast. Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, UK [Research Support, Non-U.S. Gov't Review] 2006;20(9):1496–510.
   PubMed Web of Science ®Google Scholar
• Merkerova M, Belickova M, Bruchova H. Differential expression of microRNAs in hematopoietic cell lineages. Eur J Haematol. 2008;81(4):304–10.
   PubMed Web of Science ®Google Scholar
• Starczynowski DT, Kuchenbauer F, Wegrzyn J, Rouhi A, Petriv O, Hansen CL, et al. MicroRNA-146a disrupts hematopoietic differentiation and survival. Exp Hematol. 2011;39(2):167–78 e4.
   PubMed Web of Science ®Google Scholar
• Curtale G, Citarella F, Carissimi C, Goldoni M, Carucci N, Fulci V, et al. An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood [Research Support, Non-U.S. Gov't] 2010;115(2):265–73.
   Google Scholar
• Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007;129(7):1401–14.
   PubMed Web of Science ®Google Scholar
• Vergoulis T, Vlachos IS, Alexiou P, Georgakilas G, Maragkakis M, Reczko M, et al. TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res. 2012;40(Database issue):D222–9.
   PubMedGoogle Scholar
• Labbaye C, Testa U. The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer. J Hematol Oncol. 2012;5:13.
   PubMed Web of Science ®Google Scholar
• Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011;39(Database issue):D152–7.
   PubMed Web of Science ®Google Scholar
• Dweep H, Sticht C, Pandey P, Gretz N. miRWalk – database: prediction of possible miRNA binding sites by “walking” the genes of three genomes. J Biomed Inform. [Research Support, Non-U.S. Gov't] 2011;44(5):839–47.
   Google Scholar
• Stritesky GL, Muthukrishnan R, Sehra S, Goswami R, Pham D, Travers J, et al. The transcription factor STAT3 is required for T helper 2 cell development. Immunity [Research Support, N.I.H., Extramural] 2011;34(1):39–49.
   Google Scholar
• Anderson MK, Hernandez-Hoyos G, Dionne CJ, Arias AM, Chen D, Rothenberg EV. Definition of regulatory network elements for T cell development by perturbation analysis with PU.1 and GATA-3. Dev Biol. 2002;246(1):103–21.
   PubMed Web of Science ®Google Scholar
• Jabeen R, Chang HC, Goswami R, Nutt SL, Kaplan MH. The transcription factor PU.1 regulates gammadelta T cell homeostasis. PLoS One [Research Support, N.I.H., Extramural] 2011;6(7):e22189.
   PubMed Web of Science ®Google Scholar
• Xiao G, Deng A, Liu H, Ge G, Liu X. Activator protein 1 suppresses antitumor T-cell function via the induction of programmed death 1. Proc Natl Acad Sci USA. [Research Support, Non-U.S. Gov't] 2012;109(38):15419–24.
   PubMed Web of Science ®Google Scholar
• Trampont PC, Tosello-Trampont AC, Shen Y, Duley AK, Sutherland AE, Bender TP, et al. CXCR4 acts as a costimulator during thymic beta-selection. Nat Immunol. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't] 2010;11(2):162–70.
   Google Scholar
• Curtis DJ, McCormack MP. The molecular basis of Lmo2-induced T-cell acute lymphoblastic leukemia. Clin Cancer Res. 2010;16(23):5618–23.
   PubMed Web of Science ®Google Scholar
• Sugimoto K, Maekawa Y, Kitamura A, Nishida J, Koyanagi A, Yagita H, et al. Notch2 signaling is required for potent antitumor immunity in vivo. J Immunol. [Research Support, Non-U.S. Gov't] 2010;184(9):4673–8.
   Google Scholar
• Geiger TL, Tauro S. Nature and nurture in Foxp3(+) regulatory T cell development, stability, and function. Hum Immunol. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review] 2012;73(3):232–9.
   Google Scholar
• Yu Y, Wang J, Khaled W, Burke S, Li P, Chen X, et al. Bcl11a is essential for lymphoid development and negatively regulates p53. J Exp Med. [Research Support, Non-U.S. Gov't] 2012;209(13):2467–83.
   Web of Science ®Google Scholar
• Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. [Guideline Research Support, Non-U.S. Gov't] 2009;55(4):611–22.
   Google Scholar
• Ghani S, Riemke P, Schonheit J, Lenze D, Stumm J, Hoogenkamp M, et al. Macrophage development from HSCs requires PU.1-coordinated microRNA expression. Blood 2011;118(8):2275–84.
   PubMed Web of Science ®Google Scholar
• Hadjur S, Bruno L, Hertweck A, Cobb BS, Taylor B, Fisher AG, et al. IL4 blockade of inducible regulatory T cell differentiation: the role of Th2 cells, Gata3 and PU.1. Immunol Lett. 2009;122(1):37–43.
   PubMed Web of Science ®Google Scholar
• Della Gatta G, Palomero T, Perez-Garcia A, Ambesi-Impiombato A, Bansal M, Carpenter ZW, et al. Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL. Nat Med. 2012;18(3):436–40.
   PubMed Web of Science ®Google Scholar
• Mei J, Bachoo R, Zhang CL. MicroRNA-146a inhibits glioma development by targeting Notch1. Mol Cell Biol. 2011;31(17):3584–92.
   PubMed Web of Science ®Google Scholar
• Tzoneva G, Ferrando AA. Recent Advances on NOTCH Signaling in T-ALL. Curr Top Microbiol Immunol. 2012;360:163–82.
   PubMed Web of Science ®Google Scholar
• Rohrs S, Scherr M, Romani J, Zaborski M, Drexler HG, Quentmeier H. CD7 in acute myeloid leukemia: correlation with loss of wild-type CEBPA, consequence of epigenetic regulation. J Hematol Oncol. 2010;3:15.
   PubMed Web of Science ®Google Scholar
• Wouters BJ, Jorda MA, Keeshan K, Louwers I, Erpelinck-Verschueren CA, Tielemans D, et al. Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1. Blood 2007;110(10):3706–14.
   PubMed Web of Science ®Google Scholar
• Kortum RL, Rouquette-Jazdanian AK, Samelson LE. Ras and extracellular signal-regulated kinase signaling in thymocytes and T cells. Trends Immunol. 2013;34(6):259–268.
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299(5609):1057–61.
   PubMed Web of Science ®Google Scholar
• Wachstein J, Tischer S, Figueiredo C, Limbourg A, Falk C, Immenschuh S, et al. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells. PLoS One 2012;7(12):e51747.
   PubMed Web of Science ®Google Scholar